| (Q)SA(/P)R | quantitative structure-activity (/property) relationships |
| HIV | human immunodeficiency virus |
| HAART | highly-active antiretroviral therapy |
| AIDS | acquired immune deficiency syndrome |
| RT | reverse transcriptase |
| FDA | Federal Drug Agency |
| CB | chemical-biological |
| A | activity |
| L | ligand |
| R | receptor |
| LR | Ligand-eceptor complex |